Linden Thomas Advisory Services, LLC

Position in DXCM — Dexcom Inc

CIK 1965702 Charlotte, NC

Position in DXCM

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$4,652,672

+$1,797,408 QoQ

Shares Held

69,082

+51.9% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

#279

of 966 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $23,297,411 across 10 Medical Devices names. DXCM ranks #1 (20.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DXCM	Dexcom Inc This page	69,082	$4,652,672
2	ABT	Abbott Laboratories	48,804	$4,428,474
3	SYK	Stryker Corp	11,498	$3,620,030
4	PODD	Insulet Corp	16,314	$2,483,806
5	PEN	Penumbra Inc	6,482	$2,046,691
6	BRKR	Bruker Corp	29,384	$1,768,329
7	NEOG	Neogen Corp	172,630	$1,551,943
8	BSX	Boston Scientific Corp	36,301	$1,549,326

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,652,672	69,082	+51.9%	Shares	Sole	2026-07-16
2026-03-31	$2,855,264	45,466	+64.2%	Shares	Sole	2026-04-10
2025-12-31	$1,837,718	27,689	-4.9%	Shares	Sole	2026-01-16
2025-09-30	$1,958,542	29,106	+3.8%	Shares	Sole	2025-11-06
2025-06-30	$2,447,437	28,038	+18.9%	Shares	Sole	2025-07-31
2025-03-31	$1,610,483	23,583	+8.3%	Shares	Sole	2025-04-30
2024-12-31	$1,693,208	21,772	+2.2%	Shares	Sole	2025-01-21
2024-09-30	$1,427,884	21,299	+6.0%	Shares	Sole	2024-10-17
2024-06-30	$2,278,257	20,094	+41.0%	Shares	Sole	2024-07-10
2024-03-31	$1,976,475	14,250	+6.5%	Shares	Sole	2024-04-30
2023-12-31	$1,659,827	13,376	+2.5%	Shares	Sole	2024-02-01
2023-09-30	$1,217,191	13,046	-21.8%	Shares	Sole	2023-10-20
2023-06-30	$2,144,703	16,689	+1.2%	Shares	Sole	2023-07-27
2023-03-31	$1,915,459	16,487	+3.6%	Shares	Sole	2023-04-25
2022-12-31	$1,802,894	15,921	—	Shares	Sole	2023-02-17
No filing history on record for this holder in this stock.